Promising Innovative Medicine granted to Bulevirtide for Hep D
admin 6th March 2019 Uncategorised 0MYR Pharma’s Bulevirtide has been awarded a Promising Innovative Medicine as a treatment for hepatitis D infections, indicating that the drug is a strong contender for the UK’s Early Access to Medicinces Scheme (EAMS).
More: Promising Innovative Medicine granted to Bulevirtide for Hep D
Source: News